Navigating Journal Submission Rejection An Insider's Guide

  • Search by category

  • Show all

Navigating Journal Submission Rejection An Insider's Guide

April 5, 2025
 - Tim Hardman
[wpdreams_ajaxsearchlite]

About the author

Tim Hardman

Managing Director
View profile
Dr Tim Hardman is Managing Director of Niche Science & Technology Ltd., a bespoke services CRO based in the UK. He is also Chairman of the Association of Human Pharmacology in the Pharmaceutical Industry, the representative industry body for early for early phase clinical studies in the UK, and President of the sister organisation the European Federation for Exploratory Medicines Development. Dr Hardman is a keen scientist and an occasional commentator on all aspects of medicine, business and the process of drug development.

Navigating Journal Submission Rejection An Insider's Guide

This resource from the Niche medical writing team offers insights into effectively handling manuscript rejection from academic journals.

It emphasizes that rejection is a common part of the publishing process and encourages authors to view feedback constructively.

The guide advises on how to respond to editor and reviewer comments, whether by revising and resubmitting to the same journal or choosing an alternative. It also highlights the importance of a well-prepared response letter and provides advice on assessing the type of rejection received.

Ultimately, the document aims to help authors navigate the complexities of journal submissions and increase their chances of publication.

April 5, 2025
 - Tim Hardman

Get our latest news and publications

Sign up to our news letter

© 2025 Niche.org.uk     All rights reserved

HomePrivacy policy Corporate Social Responsibility